Gossamer Bio Inc expected to post a loss of 12 cents a share - Earnings Preview

Gossamer Bio

31/07/2026 21:32

Gossamer Bio Inc GOSS.OQ GOSS.O is expected to  show a fall in quarterly revenue when it reports  results on August 3 (estimated) for the period ending June 30 2026
The San Diego California-based  company is expected to report a 54.8% decrease in revenue to $5.193 million from $11.49 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Gossamer Bio Inc is for a loss of 12 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell."  
The mean earnings estimate of analysts had risen by about 2.7% in the last three months. ​
Wall Street's median 12-month price target for Gossamer Bio Inc is $1.50, about 741.3% above its last closing price of $0.18
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.18
-0.17
-0.20
Missed
-21
Dec. 31 2026
-0.19
-0.20
-0.21
Missed
-7.3
Sep. 30 2025
-0.18
-0.19
-0.21
Missed
-9.5​
Jun. 30 2025
-0.18
-0.18
-0.17
Beat
6.1
​​Mar. 31 2025
-0.17
-0.19
-0.16
Beat
14.7
Dec. 31 2024
-0.17
-0.15
Beat
11.8​
Sep. 30 2024
-0.12
-0.15
-0.14
Beat
5.3
Jun. 30 2024
0.31
0.23
0.22
Missed
-3.9
This summary was machine generated July 31 at 20:32 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)